Oseltamivir treatment prevents the increased influenza virus disease severity and lethality occurring in chronic ethanol consuming mice

Alcoholism: Clinical and Experimental Research

Volumn 34, Issue 8, 2010, Pages 1425-1431

  Langlois, Ryan A ^a   Meyerholz, David K ^b   Coleman, Ruth A ^b   Cook, Robert T ^b   Waldschmidt, Thomas J ^a   Legge, Kevin L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Chronic Ethanol Consumption; Influenza Virus; Oseltamivir

Indexed keywords

ALCOHOL; DRINKING WATER; OSELTAMIVIR;

ADAPTIVE IMMUNITY; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; INFLUENZA; INFLUENZA VIRUS; LETHALITY; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS SHEDDING;

ALCOHOL DRINKING; ANIMALS; ETHANOL; HUMANS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; OSELTAMIVIR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VIRAL LOAD;

MUS; ORTHOMYXOVIRIDAE;

EID: 77954933960     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01226.x     Document Type: Article

References (36)

1. Amin PB, Diebel LN, Liberati DM (2009) Dose-dependent effects of ethanol and E. coli on gut permeability and cytokine production. J Surg Res 157 : 187 192.
2. Anderson LM, Chhabra SK, Nerurkar PV, Souliotis VL, Kyrtopoulos SA (1995) Alcohol-related cancer risk: a toxicokinetic hypothesis. Alcohol 12 : 97 104.
3. Baz M, Abed Y, McDonald J, Boivin G (2006) Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 43 : 1555 1561.
4. Bird MD, Kovacs EJ (2008) Organ-specific inflammation following acute ethanol and burn injury. J Leukoc Biol 84 : 607 613.
5. Bode C, Bode JC (2005) Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 29 (11 Suppl 166S 171S.
6. Brown LA, Cook RT, Jerrells TR, Kolls JK, Nagy LE, Szabo G, Wands JR, Kovacs EJ (2006) Acute and chronic alcohol abuse modulate immunity. Alcohol Clin Exp Res 30 : 1624 1631.
7. Brown LA, Harris FL, Ping XD, Gauthier TW (2004) Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathione availability? Alcohol 33 : 191 197.
8. Burger RA, Billingsley JL, Huffman JH, Bailey KW, Kim CU, Sidwell RW (2000) Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. Immunopharmacology 47 : 45 52.
9. Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, Mador N, Greenbaum E, Wolf DG (2009) Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol 44 : 138 140.
10. Coleman RA, Young BM, Turner LE, Cook RT (2008) A practical method of chronic ethanol administration in mice. Methods Mol Biol 447 : 49 59.
11. Cook RT (1998) Alcohol abuse, alcoholism, and damage to the immune system - a review. Alcohol Clin Exp Res 22 : 1927 1942.
12. Cook RT, Schlueter AJ, Coleman RA, Tygrett L, Ballas ZK, Jerrells TR, Nashelsky MB, Ray NB, Haugen TH, Waldschmidt TJ (2007) Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion - absence of subset-specific glucocorticoid-induced immune cell loss. Alcohol Clin Exp Res 31 : 1746 1758.
13. Cook RT, Zhu X, Coleman RA, Ballas ZK, Waldschmidt TJ, Ray NB, LaBrecque DR, Cook BL (2004) T-cell activation after chronic ethanol ingestion in mice. Alcohol 33 : 175 181.
14. De Clercq E (2006) Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5 : 1015 1025.
15. Gurung P, Young BM, Coleman RA, Wiechert S, Turner LE, Ray NB, Waldschmidt TJ, Legge KL, Cook RT (2009) Chronic ethanol induces inhibition of antigen-specific CD8+ but not CD4+ immunodominant T cell responses following Listeria monocytogenes inoculation. J Leukoc Biol 85 : 34 43.
16. Happel KI, Nelson S (2005) Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc 2 : 428 432.
17. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG (2006a) Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 193 : 760 764.
18. Ison MG, Mishin VP, Braciale TJ, Hayden FG, Gubareva LV (2006b) Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection. J Infect Dis 193 : 765 772.
19. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC (2008) Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 27 : 282 288.
20. von Itzstein M (2007) The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 6 : 967 974.
21. Jerrells TR, Pavlik JA, DeVasure J, Vidlak D, Costello A, Strachota JM, Wyatt TA (2007) Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice. Alcohol 41 : 357 369.
22. Joshi PC, Guidot DM (2007) The alcoholic lung: epidemiology, pathophysiology, and potential therapies. Am J Physiol Lung Cell Mol Physiol 292 : L813 L823.
23. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ (2009) Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 50 : 538 547.
24. Laizure SC, Mandrell T, Gades NM, Parker RB (2003) Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos 31 : 16 20.
25. Lieber CS (2005) Metabolism of alcohol. Clin Liver Dis 9 : 1 35.
26. Meyerholz DK, Edsen-Moore M, McGill J, Coleman RA, Cook RT, Legge KL (2008) Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol 181 : 641 648.
27. Nagata K, Suzuki H, Sakaguchi S (2007) Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 32 : 453 468.
28. Ness KJ, Fan J, Wilke WW, Coleman RA, Cook RT, Schlueter AJ (2008) Chronic ethanol consumption decreases murine Langerhans cell numbers and delays migration of Langerhans cells as well as dermal dendritic cells. Alcohol Clin Exp Res 32 : 657 668.
29. Nichols WG, Guthrie KA, Corey L, Boeckh M (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39 : 1300 1306.
30. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4 : e1000115.
31. Shi D, Yang J, Yang D, LeCluyse EL, Black C, You L, Akhlaghi F, Yan B (2006) Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther 319 : 1477 1484.
32. Song K, Coleman RA, Zhu X, Alber C, Ballas ZK, Waldschmidt TJ, Cook RT (2002) Chronic ethanol consumption by mice results in activated splenic T cells. J Leukoc Biol 72 : 1109 1116.
33. Stohr K (2003) Preventing and treating influenza. BMJ 326 : 1223 1224.
34. Tang Y, Forsyth CB, Farhadi A, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, Keshavarzian A (2009) Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res 33 : 1220 1230.
35. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79 : 14933 14944.
36. Zhu HJ, Markowitz JS (2009) Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants. Drug Metab Dispos 37 : 264 267.